Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

The Carlyle Group Inc. - Common Stock (NQ: CG )

38.50 +1.91 (+5.22%)
Streaming Delayed Price Updated: 12:23 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 538,223
Open 36.95
Bid (Size) 38.47 (3)
Ask (Size) 38.53 (2)
Prev. Close 36.59
Today's Range 36.63 - 38.52
52wk Range 33.02 - 57.50
Shares Outstanding 354,462,148
Dividend Yield 3.64%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Socially Determined and Acentra Health Partner to Advance Whole Person, Whole Population Healthcare through Enhanced Analytics
From Acentra Health
Via GlobeNewswire
Is Carlyle Group Gaining or Losing Market Support?
Via Benzinga

Performance

YTD
-24.11%
-24.11%
1 Month
-16.74%
-16.74%
3 Month
-32.00%
-32.00%
6 Month
-21.83%
-21.83%
1 Year
-16.90%
-16.90%

More News

Read More
SoftBank Buys Silicon Valley Firm As It Goes All-In On AI
Via Talk Markets
Topics Artificial Intelligence Stocks / Equities
Exposures Artificial Intelligence
Masayoshi Son's SoftBank Buys Oracle-Backed Ampere For $6.5 Billion To Boost US AI Push
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
What's Driving the Market Sentiment Around Carlyle Group?
Via Benzinga
Earnings Scheduled For February 20, 2025
Via Benzinga
The Analyst Verdict: Carlyle Group In The Eyes Of 6 Experts
Via Benzinga
Oppenheimer Analysts Slash Estimates For Goldman Sachs, Jefferies Amid Subdued M&A Activity
Via Benzinga
Tariffs Tangle Markets, Businesses, Investors
Via The Motley Fool
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
Via Benzinga
What's Going On With Gene Therapy Company Bluebird Bio Stock Today?
Via Benzinga
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
From bluebird bio, Inc.
Via Business Wire
The Analyst Verdict: Carlyle Group In The Eyes Of 14 Experts
Via Benzinga
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
Via Benzinga
Carlyle Group Stock Slips After Q4 Profit Miss: Retail Remains Neutral
Via Stocktwits
Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair
From Acentra Health
Via GlobeNewswire
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy Company
From Vantive
Via GlobeNewswire
Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer
From Acentra Health
Via GlobeNewswire
Copia Power and Arizona Public Service (APS) Enter Into 20-Year Power Purchase Agreements for Large-Scale Solar and Storage Energy Campus
Via ACCESS Newswire
The Analyst Verdict: Carlyle Group In The Eyes Of 14 Experts
Via Benzinga
2025 Industry Shake-Up: Goldman Highlights KKR, Raymond James, Hamilton Lane
Via Benzinga
Bank Of America Raises Bullish Outlook On US Brokers, Exchanges, Alternative Investments: 3 Top Picks For 2025
Via Benzinga
TeamViewer Agrees To Acquire Carlyle-Backed 1E For $720 Million: Details
Via Benzinga
Acentra Health’s Independent Medical Review Division Earns Accreditation from Leading Care Quality and Safety Organization
From Acentra Health
Via GlobeNewswire
These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Via MarketBeat
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.